중환자 환자의 웰빙 향상 및 중환자실 후 증후군 예방을 위한 최면 (HypnoPICS)
중환자 건강 증진 및 중환자실 후 증후군 예방을 위한 최면 요법
The goal of this clinical trial is to evaluate the effectiveness of a hypnosis intervention in improving well-being at day 28 of an ICU stay. The main question it aims to answer is :
-Does Hypnosis intervention at ICU discharge and on day 7 and 14 on the wards if the patient remains in the hospital, improve wellbeing at 28 days ?
Researchers will compare discharged ICU patients who received standard post-discharge care to discharged ICU patients who received standard post-discharge care and hypnosis intervention on discharge and 7 and 14days after if they are still in the hospital, to see if hypnosis can improve their wellbeing.
Participants will receive a hypnosis session on the day of ICU discharge, a second session seven days post-discharge and a third session at day 14 if they are still in the hospital.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
상세 설명
Critically ill patients in the Intensive Care Unit (ICU) face numerous challenges both acutely and in the long term. These patients frequently experience acute pain and anxiety due to intubation and induced comas. Following their ICU discharge, they commonly report decreased well-being and quality of life. Additionally, up to 40% of critically ill patients develop post-intensive care syndrome (PICS), which includes mental, physical, and cognitive sequelae that can persist up to one year after discharge. Heavy sedation and medications necessary to manage pain and anxiety are known risk factors for PICS.
The current standard of care in the ICU includes mobilization and nutrition, pain control, and family engagement and empowerment. Furthermore, no other specific interventions are aimed at improving long-term outcomes and preventing PICS.
Several studies have explored using hypnosis to improve the acute care of ICU patients. For instance, a pain protocol that included hypnosis in burn patients hospitalized in the CHUV (Centre Hospitalier Universitaire Vaudois) resulted in reduced pain intensity, reduced opioid use, reduced anxiety, and better wound outcomes, all while lowering costs. A pilot study involving non-invasive ventilation patients showed that hypnosis could improve comfort, mask tolerance, and anxiety levels. Additionally, studies on relaxation therapy have indicated that electronic relaxation therapy is a promising, safe, and effective non-pharmacological solution to enhance overall comfort in alert and non-delirious ICU patients.
However, despite these efforts, there is a lack of efficient interventions specifically targeting the wellbeing of patients after an ICU stay and the prevention of PICS. Existing interventions, such as follow-up programs, rehabilitation, and psychological follow-up, have shown conflicting results. To date, no studies have specifically assessed the effect of hypnosis on the short and longer-term well-being of critically ill patients leaving the ICU and its possible effect on the prevention of PICS.
The investigators hypothesize that providing a hypnosis session at ICU discharge and followed by subsequent sessions on days 7 and 14 on the ward will improve well-being in the short term and reduce PICS symptoms at 3-months. The primary outcome will be the assessment of well-being at day 28 post-ICU discharge. Secondary outcomes will be anxiety, depression, PTSD, and quality of life at three months.
Hypothesis and primary objective The investigators hypothesize that providing intervention with hypnosis at ICU discharge and subsequent sessions on day 7 and 14 on the ward if the patient remains in the hospital will improve wellbeing at day 28 and reduce PICS symptoms at three months in critically ill patients.
Primary Objective:
The primary objective of this study is to evaluate the effectiveness of a hypnosis intervention in improving well-being at day 28 of an ICU stay.
Scale used for wellbeing:
- ESAS, total 90, each item on a 0-10 scale
- EQ-5D-5L
Secondary Objectives:
-
To assess the impact of a hypnosis intervention to improve PICS at 3 months
- Anxiety and depression: PHQ-9 et GAD-7
- Post-traumatic stress disorder: PDI and IES-R scale
- Quality of life: SF-12, EQ-5D-5L and WHODAS 2.0
- Patient impression of change: PGIC
-
To evaluate patient immediate wellbeing after the hypnosis intervention. • ESAS before after the session in patients who will get the session
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Hannah Wozniak, Medical Doctor
- 전화번호: +41
- 이메일: hannah-wozniak@hug.ch
연구 연락처 백업
- 이름: Jennifer B. C. S Muradbegovic, Doctor
- 전화번호: +41 79 55 36255
- 이메일: jennifer.cau@hug.ch
연구 장소
-
-
-
Geneva, 스위스, 1205
- 모병
- University Hospital of Geneva
-
연락하다:
- Hannah Wozniak, Medical Doctor
- 전화번호: +41
- 이메일: hannah-wozniak@hug.ch
-
연락하다:
- Jennifer Muradbegovic, Doctor
- 전화번호: +41 79 55 36255
- 이메일: jennifer.cau@hug.ch
-
Neuchâtel, 스위스
- 아직 모집하지 않음
- Hôpitaux Neuchâtelois
-
연락하다:
- Marie-Eve Brunner, Medical Doctor
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- On Mechanical Ventilation for at least 2 days
- Able to give informed consent as documented by signature
- French speaking
Exclusion Criteria:
- Refusal of the patient
- Patient transferred from another ICU
- Patient is planned for a withdrawal of care or is actively dying
- Glasgow coma scale (GCS) <15 on ICU discharge
- Patient presenting with delirium (detected by CAM-ICU) on ICU discharge
- Patient hospitalized for traumatic brain injury
- Patient is in jail
- Patient hospitalized for more than 28 days in the ICU
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 방지
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: Hypnosis group
Participants in the intervention group will receive a hypnosis session on the day of discharge, a second session seven days post-discharge, and a third session on day 14 if they are still in the hospital. Trained professionals will conduct the hypnosis sessions following a standardized protocol, designed by the study team for critically ill patients. |
the hypnosis will be tailored to each patient. Key elements will include relaxation (to mitigate anxiety and stress and help the patient feel more comfortable, secure, and competent), reassociation techniques (to help the patient reconnect with their body, promoting a sense of embodiment and presence), and safe place (to introduce a safe and calming place to instill a sense of control and competence, aiding in emotional stabilization and fostering a sense of safety and well-being). |
|
간섭 없음: Control group
Participants in the control group will receive standard post-discharge care, which includes mobilization, nutrition, pain control, and family engagement and empowerment, without any hypnosis intervention. |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Wellbeing at day 28 post intensive care unit discharge
기간: Day 28 post intensive care unit discharge
|
ESAS scale (Edmonton Symptom Assessment System) with a range from 0 to 100. Higher scores means worse wellbeing. |
Day 28 post intensive care unit discharge
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Immediate wellbeing following a hypnosis session
기간: Day 1 (Day of discharge from ICU), day 7, day 14
|
1) ESAS scale before and after the hypnosis session performed on Day 1 (ICU discharge), Day 7 and D14 -The ESAS scale (Edmonton Symptom Assessment System) has a range from 0 to 100. |
Day 1 (Day of discharge from ICU), day 7, day 14
|
|
PDI - Peritraumatic distress inventory
기간: day 28 post ICU discharge
|
PDI (Peritraumatic distress index, range: 13-65) |
day 28 post ICU discharge
|
|
PHQ-9 - Patient Health Questionnaire-9
기간: Day 28 post intensive care unit discharge and 3 months post intensive care
|
PHQ-9 (Patient Health Questionnaire-9: range 0-27) will be used to assess depressive symptoms at day 28 and 3 months |
Day 28 post intensive care unit discharge and 3 months post intensive care
|
|
GAD-7 - Generalized Anxiety Disorder-7
기간: at day 28 and 3 months post ICU discharge
|
GAD-7 (Generalized Anxiety Disorder-7, range 0-21) will be used to assess anxiety symptoms at day 28 and 3 months post ICU discharge |
at day 28 and 3 months post ICU discharge
|
|
IES-R (Impact of event Scale)
기간: 3 months post intensive care unit discharge. Higher score means more PTSD symptoms.
|
Range: 0-88 |
3 months post intensive care unit discharge. Higher score means more PTSD symptoms.
|
|
EQ-5D-5L (Quality of life)
기간: Day 28 post intensive care unit discharge and 3 months post intensive care unit discharge
|
Part 1) 5 dimensions: Mobility, Self-care, Usual activities, Pain/discomfort, Anxiety/depression. The 5-digit health state is converted (via country-specific value set) to an index value Part 2) EQ VAS (Visual Analog Scale). Patient rates their health today from 0 to 100. Higher scores mean better quality of life. |
Day 28 post intensive care unit discharge and 3 months post intensive care unit discharge
|
|
PGIC - Patient Global Impression of Change
기간: Day 28 post intensive care unit discharge and 3 months post intensive care unit discharge
|
Single-item global rating of how much the patient feels their condition has changed since a reference time. Higher scores means improvement. Scoring / range: 1-7 |
Day 28 post intensive care unit discharge and 3 months post intensive care unit discharge
|
공동 작업자 및 조사자
수사관
수사관
- 수석 연구원: Hannah Wozniak, Medical Doctor, University Hospital, Geneva
- 수석 연구원: Matteo Coen, MD, PHD, University Hospital, Geneva
간행물 및 유용한 링크
일반 간행물
- Schmidt B, Schneider J, Deffner T, Rosendahl J. Hypnotic suggestions of safety improve well-being in non-invasively ventilated patients in the intensive care unit. Intensive Care Med. 2021 Apr;47(4):485-486. doi: 10.1007/s00134-021-06364-8. Epub 2021 Feb 16. No abstract available.
- Spiegel D, Cardena E. New uses of hypnosis in the treatment of posttraumatic stress disorder. J Clin Psychiatry. 1990 Oct;51 Suppl:39-43; discussion 44-6.
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
키워드
추가 관련 MeSH 약관
기타 연구 ID 번호
기타 연구 ID 번호
- 2025-00369
- 2025 (미국 NIH 보조금/계약)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .